IOMG Organization - National Center for Rehabilitative Auditory Research (NCRAR)
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

National Center for Rehabilitative Auditory Research (NCRAR)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

IOMG Organization

IOMG Leadership:

  • Committee Chair: Dawn Konrad-Martin from National Center for Rehabilitative Auditory Research (NCRAR), a Research Center of the US Veterans Affairs (VA), Rehabilitation Research and Development Service
  • Outreach and Dissemination Chair: Khaya Clark from HCE (Hearing Center of Excellence)/NCRAR
  • International Emphasis Chair: Lucretia Peterson from University of Cape Town, South Africa 
  • Ototoxicity of Aminoglycoside Treatment Co-Chairs: Angela Garinis from OHSU and Peter Steyger from Creighton UniversityEnvironmental Ototoxicity Chair:
  • Ototoxicity of Cancer Treatment Co-Chairs: Carmen Brewer from the National Institute of Health (NIH) and Gayla Poling from Mayo Clinic
  • Ototoxicity of Environmental and Occupational Exposures Chair: Thais C. Morata from the National Institute for Occupational Safety and Health (NIOSH), Cincinnati, OH, USA, part of the Centers for Disease Control and Prevention

Subgroups by Focus Area:

International Emphasis

  • Subgroup: Africa (Lead, Lucretia Petersen from University of Cape Town, South Africa)
  • Subgroup: China (Lead, Wei Qiu, from State University of New York at Plattsburgh)
  • Subgroup: Europe (Lead, Ghada Al-Malky, from University College of London, UK)

Ototoxicity of Aminoglycoside Treatment

  • Subgroup: VA Ototoxicity Management (Trisha Milnes from Charlie Norwood VA, Georgia, and Dawn Konrad-Martin from NCRAR)
  • Subgroup: Cystic Fibrosis Recommendations (Co-Leads: Angela Garinis [OHSU], Carmen Brewer [NIH], Gayla Poling [Mayo Clinic]) (Click here for more information)
  • Subgroup: Non-TB Mycobacterium, TB, MRSA Recommendations (Leads to be determined)

Ototoxicity of Cancer Treatment

  • Subgroup: VA Ototoxicity Management (Trisha Milnes, Dawn Konrad-Martin)
  • Subgroup: Enhanced screening measures, includine for speech understanding (Co-leads: Lisa Hunter from Cincinnati Children’s Hospital, Ohio, and Riley Debacker from The Ohio University, Ohio)

Ototoxicity of Environmental and Occupational Exposures